0001181431-13-032894.txt : 20130605
0001181431-13-032894.hdr.sgml : 20130605
20130605163029
ACCESSION NUMBER: 0001181431-13-032894
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130603
FILED AS OF DATE: 20130605
DATE AS OF CHANGE: 20130605
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gregory Philip D
CENTRAL INDEX KEY: 0001343543
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 13894615
MAIL ADDRESS:
STREET 1: POINT RICHMOND TECH CENTER II
STREET 2: 501 CANAL BOULEVARD SUITE A100
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
rrd382519.xml
FORM 4
X0306
4
2013-06-03
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001343543
Gregory Philip D
C/O SANGAMO BIOSCIENCES INC.
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
Vice President, Research & CSO
Common Stock
2013-06-03
4
M
0
3000
3.45
A
93000
D
Common Stock
2013-06-03
4
S
0
3000
7.88
D
90000
D
Employee Stock Option (Right to Buy)
3.45
2013-06-03
4
M
0
3000
0.00
D
2018-12-09
Common Stock
3000
126709
D
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2012.
Includes 50,000 shares and 40,000 shares subject to restricted stock units granted on December 8, 2011 and December 6, 2012, respectively, which will be issued as such units vest in accordance with their terms.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.88 to $7.8801,
inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
All shares underlying this option are vested and immediately exercisable.
/s/ Florence Tam, attorney-in-fact
2013-06-04